Pulsed Acoustic Cellular Expression (PACE) is a proprietary form of Extracorporeal Shock Wave Technology (ESWT) that utilizes high-energy acoustic pressure waves in the shock wave spectrum created through an electrohydraulic method. The PACE device consists of a console and applicator.

PACE Energy Causes Mechanical Stresses on Cells

Shock waves are characterized by a high pressure amplitude (510 bar), rapid rise time (<33ns) and short life cycle (2 – 8µs). Their frequency spectrum ranges from the audible to the ultrasonic region (16Hz – 20MHz).


dermaPACE is currently under review by the U.S. Food and Drug Administration (FDA) for Premarket Approval and is not available for sale or distribution in the U.S.